SuperworthNiagen Bioscience market cap NAGE
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $192.3M
- Highest close in our data
- $1.1B
- Jun 2025
Niagen Bioscience is worth $192.3M at the close on Oct 23, 2026, at $2.43 a share.
That is down 68% over the last year and down 54% over five years.
Its highest close in our data was $1.1B in Jun 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $192.3M | $192.3M | $520.3M | −64% |
| 2025 | $529.9M | $402.5M | $1.1B | +26% |
| 2024 | $421.6M | $105.2M | $589.7M | +292% |
| 2023 | $107.4M | $96.8M | $163.1M | −14% |
| 2022 | $125.1M | $82.7M | $226M | −51% |
| 2021 | $255.4M | $255.4M | $860.7M | −14% |
| 2020 | $296.6M | $163.8M | $342.6M | +11% |
| 2019 | $266.3M | $158.8M | $274.7M | +42% |
| 2018 | $187.3M | $166.4M | $303.6M | −34% |
| 2017 | $283.3M | $86.4M | $333.5M | +126% |
| 2016 | $125.5M | $87.6M | $210.6M | −6% |
| 2015 | $133.1M | $90.9M | $163.2M | +35% |
| 2014 | $98.4M | $98.4M | $214.9M | −41% |
| 2013 | $167.8M | $51M | $167.8M | +223% |
| 2012 | $51.9M | $43.8M | $89.9M | +29% |
| 2011 | $40.1M | $40.1M | $78.9M | n/a |
Against its peers
Companies in Chemicals nearest Niagen Bioscience's size, closest first, today.
| Company | Market cap |
|---|---|
| NAGENiagen Bioscience | $192.3M |
| FTLFFitlife Brands | $78.4M |
| FTKFlotek Industries | $865.7M |
| BTMDbiote | $38.4M |
| CRONCronos | $1.2B |
| Peer median | $472M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Niagen Bioscience
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.